FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092200541> ?p ?o ?g. }

• W3092200541 endingPage "44" @default.
• W3092200541 startingPage "37" @default.
• W3092200541 abstract "Objective The objectives were to define the maximum tolerated dose (MTD), safety profile and pharmacokinetics (PKs) of intraperitoneal oxaliplatin delivered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with advanced peritoneal carcinomatosis from gastrointestinal tract cancers. Methods PIPAC was applied every 4–6 weeks, for 5 cycles, in a phase I dose-escalation study using a 3 + 3 design. The first dose level was 90 mg/m2 with planned increases of 50 mg/m2 per level. Platinum concentration was measured in plasma, tissues and intraperitoneal fluid samples. The trial was registered at ClinicalTrials.gov (NCT03294252). Results Ten patients with 33 PIPAC sessions were included. No dose limiting toxicity (DLT) occurred at 90 mg/m2 and two at 140 mg/m2. The MTD was therefore set at 90 mg/m2. Overall treatment included a median number of three PIPAC sessions (range: 1–5) and secondary complete cytoreductive surgery for two patients. Overall safety showed 67 grade I–II and 11 grade III–IV toxicities, usually haematologic, digestive (nausea/vomiting, abdominal pain), and fatigue. Oxaliplatin concentrations were three- to four-fold higher in tissue in contact with aerosol than in muscle without contact. At 140 mg/m2, the plasma oxaliplatin concentration was high with Cmax and area under the curve (AUC)0–48h of 1035 μg/l and 9028 μg h/L, respectively. Conclusions The MTD of oxaliplatin during PIPAC is 90 mg/m2. PK data demonstrate a high tumour concentration and a significant systemic absorption." @default.
• W3092200541 created "2020-10-15" @default.
• W3092200541 creator A5019510003 @default.
• W3092200541 creator A5022131781 @default.
• W3092200541 creator A5029973306 @default.
• W3092200541 creator A5031036666 @default.
• W3092200541 creator A5035953226 @default.
• W3092200541 creator A5044362168 @default.
• W3092200541 creator A5050098537 @default.
• W3092200541 creator A5063861233 @default.
• W3092200541 creator A5071502431 @default.
• W3092200541 creator A5073110430 @default.
• W3092200541 creator A5073706980 @default.
• W3092200541 creator A5075768610 @default.
• W3092200541 creator A5076430372 @default.
• W3092200541 date "2020-11-01" @default.
• W3092200541 modified "2023-10-17" @default.
• W3092200541 title "A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers" @default.
• W3092200541 cites W17791541 @default.
• W3092200541 cites W1927044883 @default.
• W3092200541 cites W2038109956 @default.
• W3092200541 cites W2041574270 @default.
• W3092200541 cites W2055953960 @default.
• W3092200541 cites W2063532696 @default.
• W3092200541 cites W2073581648 @default.
• W3092200541 cites W2084346269 @default.
• W3092200541 cites W2094313851 @default.
• W3092200541 cites W2109498035 @default.
• W3092200541 cites W2109794223 @default.
• W3092200541 cites W2116274195 @default.
• W3092200541 cites W2117190139 @default.
• W3092200541 cites W2124410855 @default.
• W3092200541 cites W2128328462 @default.
• W3092200541 cites W2141665958 @default.
• W3092200541 cites W2143086668 @default.
• W3092200541 cites W2147485225 @default.
• W3092200541 cites W2159179344 @default.
• W3092200541 cites W2170008162 @default.
• W3092200541 cites W2240042172 @default.
• W3092200541 cites W2286695651 @default.
• W3092200541 cites W2331770005 @default.
• W3092200541 cites W2415137199 @default.
• W3092200541 cites W2418164823 @default.
• W3092200541 cites W2796242903 @default.
• W3092200541 cites W2800787543 @default.
• W3092200541 cites W2805520724 @default.
• W3092200541 cites W2809581078 @default.
• W3092200541 cites W2889646458 @default.
• W3092200541 cites W2919939945 @default.
• W3092200541 cites W2944802824 @default.
• W3092200541 cites W2954661925 @default.
• W3092200541 cites W4362207802 @default.
• W3092200541 doi "https://doi.org/10.1016/j.ejca.2020.09.010" @default.
• W3092200541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33039812" @default.
• W3092200541 hasPublicationYear "2020" @default.
• W3092200541 type Work @default.
• W3092200541 sameAs 3092200541 @default.
• W3092200541 citedByCount "32" @default.
• W3092200541 countsByYear W30922005412020 @default.
• W3092200541 countsByYear W30922005412021 @default.
• W3092200541 countsByYear W30922005412022 @default.
• W3092200541 countsByYear W30922005412023 @default.
• W3092200541 crossrefType "journal-article" @default.
• W3092200541 hasAuthorship W3092200541A5019510003 @default.
• W3092200541 hasAuthorship W3092200541A5022131781 @default.
• W3092200541 hasAuthorship W3092200541A5029973306 @default.
• W3092200541 hasAuthorship W3092200541A5031036666 @default.
• W3092200541 hasAuthorship W3092200541A5035953226 @default.
• W3092200541 hasAuthorship W3092200541A5044362168 @default.
• W3092200541 hasAuthorship W3092200541A5050098537 @default.
• W3092200541 hasAuthorship W3092200541A5063861233 @default.
• W3092200541 hasAuthorship W3092200541A5071502431 @default.
• W3092200541 hasAuthorship W3092200541A5073110430 @default.
• W3092200541 hasAuthorship W3092200541A5073706980 @default.
• W3092200541 hasAuthorship W3092200541A5075768610 @default.
• W3092200541 hasAuthorship W3092200541A5076430372 @default.
• W3092200541 hasConcept C112705442 @default.
• W3092200541 hasConcept C121608353 @default.
• W3092200541 hasConcept C126322002 @default.
• W3092200541 hasConcept C126894567 @default.
• W3092200541 hasConcept C22979827 @default.
• W3092200541 hasConcept C2776694085 @default.
• W3092200541 hasConcept C2780580376 @default.
• W3092200541 hasConcept C2780852908 @default.
• W3092200541 hasConcept C2780962732 @default.
• W3092200541 hasConcept C31760486 @default.
• W3092200541 hasConcept C42219234 @default.
• W3092200541 hasConcept C526805850 @default.
• W3092200541 hasConcept C71924100 @default.
• W3092200541 hasConcept C90924648 @default.
• W3092200541 hasConceptScore W3092200541C112705442 @default.
• W3092200541 hasConceptScore W3092200541C121608353 @default.
• W3092200541 hasConceptScore W3092200541C126322002 @default.
• W3092200541 hasConceptScore W3092200541C126894567 @default.
• W3092200541 hasConceptScore W3092200541C22979827 @default.
• W3092200541 hasConceptScore W3092200541C2776694085 @default.
• W3092200541 hasConceptScore W3092200541C2780580376 @default.
• W3092200541 hasConceptScore W3092200541C2780852908 @default.

• next